GO:0006546 glycine catabolic process explained

Glycine catabolic process (GO:0006546) is the biological process comprising the chemical reactions and pathways that result in the breakdown of glycine. Glycine is the smallest amino acid and serves as a precursor for proteins, glutathione, creatine, heme, and purines, so its degradation must be tightly balanced with biosynthesis and one-carbon supply. The term is therefore central to understanding how cells dispose of excess glycine and how they route its carbon and nitrogen into other metabolic pathways. In eukaryotes, the best-characterized glycine catabolic route is the mitochondrial glycine cleavage system (GCS), which reversibly converts glycine into carbon dioxide, ammonia, and a one-carbon unit carried by tetrahydrofolate. This reaction connects glycine breakdown to serine hydroxymethyltransferase (SHMT) activity and to the broader folate cycle, making glycine catabolism a node in cancer metabolism and in metabolic homeostasis of skeletal muscle. In bacteria and anaerobic organisms, additional glycine catabolic strategies exist, including the glycine reductase pathway and Stickland-type fermentation reactions that support energy conservation. For researchers, GO:0006546 is a useful annotation anchor because it distinguishes true glycine breakdown from glycine biosynthesis, glycine conjugation, and glycine transport. Accurate interpretation of this term matters when designing CRISPR screens, metabolic flux experiments, or disease models, since loss of a catabolic enzyme can shift glycine pools, one-carbon availability, and redox balance.

In plain terms, GO:0006546 describes all the biochemical steps by which a cell or organism breaks glycine down into smaller products. The QuickGO definition states that it is the chemical reactions and pathways resulting in the breakdown of glycine. This includes oxidative cleavage of glycine by the glycine cleavage system, conversion of glycine to serine and subsequent oxidation, and organism-specific catabolic routes such as glycine reductase in anaerobes. The term is a biological process annotation and should not be confused with glycine biosynthetic process, glycine transport, or glycine conjugation, which are separate GO terms.

Glycine catabolic process is important because glycine sits at the intersection of protein synthesis, one-carbon metabolism, redox homeostasis, and detoxification. When glycine breakdown is perturbed, cells can accumulate glycine, alter folate-dependent methylation, and change flux into nucleotide and glutathione synthesis, with consequences for cancer cell proliferation and for normal tissue homeostasis. In clinical pharmacology, glycine conjugation is a major route for detoxifying xenobiotic carboxylic acids, and interindividual variation in this pathway affects drug handling. In anaerobes, glycine catabolism supports energy conservation and carbon flow, illustrating the deep evolutionary conservation of this process.

The following genes and proteins are directly or closely associated with glycine catabolic process, based on published literature on glycine cleavage, serine-glycine interconversion, and related metabolic routes.

Glycine catabolic process is regulated at multiple levels. The glycine cleavage system is sensitive to the availability of its substrates and cofactors, including glycine, NAD+, and tetrahydrofolate, and its flux is coupled to the folate cycle and one-carbon demand. In cancer cells, expression of GLDC and other GCS components can be altered to support proliferation and redox balance. In skeletal muscle, glycine metabolism is influenced by nutritional status and metabolic homeostasis, with implications for creatine and glutathione synthesis. In bacteria, glycine catabolic pathways are regulated in response to oxygen availability and electron acceptor supply. Additionally, glycine conjugation capacity varies between individuals due to genetic and environmental factors, indirectly affecting the glycine pool available for catabolism.

Glycine catabolic process is rewired in many cancers. The glycine cleavage system and serine-glycine interconversion support one-carbon metabolism, which is required for nucleotide synthesis and methylation reactions during rapid proliferation. GLDC expression has been linked to cancer cell survival and metabolic adaptation, making GCS components candidate targets for metabolic anticancer strategies. Isotope tracing and CRISPR knockout studies are commonly used to test the contribution of glycine catabolism to tumor growth.

Defects in the glycine cleavage system cause glycine encephalopathy (non-ketotic hyperglycinemia), a severe inherited disorder characterized by elevated glycine levels and neurological impairment. Mutations in GLDC, AMT, and GCSH are associated with this condition, and model systems are used to study the biochemical consequences of impaired glycine catabolism. These disorders illustrate the importance of glycine catabolic process for normal brain function.

Glycine metabolism in skeletal muscle contributes to metabolic homeostasis, including creatine synthesis and glutathione production. Alterations in glycine catabolic flux may influence muscle function and systemic metabolic balance, although the precise mechanisms are still being investigated. Research in this area uses metabolic tracing and muscle cell models to dissect glycine handling.

Glycine conjugation, which competes with glycine catabolism for the same amino acid pool, is important for detoxifying xenobiotic carboxylic acids. Interindividual variation in glycine N-acyltransferase activity can affect drug clearance and toxicity. Understanding how glycine is partitioned between conjugation and catabolism is therefore relevant to clinical pharmacology.

Stable isotope tracing with labeled glycine or serine is a primary method to measure glycine catabolic flux and its contribution to one-carbon metabolism. By tracking labeled carbons into downstream metabolites such as formate, nucleotides, or methionine, researchers can quantify pathway activity in cells and tissues. This approach is often combined with mass spectrometry to resolve isotopic enrichment.

CRISPR-based knockout and point-mutation models allow causal testing of genes involved in glycine catabolic process. Pooled screens can identify which GCS or serine-glycine pathway genes are required for proliferation under specific metabolic conditions. These screens are particularly useful in cancer cell lines with defined metabolic dependencies.

RNA sequencing and proteomics can reveal changes in expression of glycine catabolic enzymes across conditions or disease states. Enrichment analysis using GO:0006546 helps interpret whether glycine catabolism is coordinately regulated with other metabolic pathways. Such datasets are often integrated with metabolic flux data for a systems-level view.

Direct measurement of glycine cleavage system activity or glycine N-acyltransferase activity provides biochemical validation of catabolic function. These assays can be performed in cell lysates or with recombinant proteins, and they complement genetic and flux-based approaches. They are especially useful for characterizing point mutations identified in patient samples.

Researchers studying glycine catabolic process-related genes often need to determine whether a candidate gene is causally involved in glycine breakdown, one-carbon supply, or disease-relevant metabolic remodeling. EDITGENE provides CRISPR-based cell model services that enable precise, reproducible testing of these hypotheses in relevant cell types.

Glycine catabolic process (GO:0006546) is a fundamental metabolic pathway that connects glycine breakdown to one-carbon metabolism, energy conservation, and detoxification. Its dysregulation is relevant to cancer, inherited metabolic disorders, skeletal muscle homeostasis, and drug metabolism. Understanding the genes and mechanisms involved provides a foundation for metabolic research and therapeutic targeting. CRISPR-based cell models, combined with isotope tracing and multi-omics methods, offer powerful tools to dissect glycine catabolic process in health and disease. EDITGENE supports these efforts with customized knockout, point-mutation, knock-in, overexpression, and screening services.